Valuation
- Market cap
- 12,293,000
- Revenue TTM
- $0
- Net income TTM
- $-26,180,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 78,900
- Avg volume
- 150,958
- Day's range
- $1.38 – $1.64
- Shares out
- 8,087,000
- Stochastic %K
- 9%
- Beta
- 0.51
- Analysts
- Strong Buy
- Price target
- $21.75
Company profile
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of de...
Show more
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 833-304-0323
- Website
- https://www.quantumbiopharma.com
- Address
- 1 Adelaide Street East, Suite 801, Toronto, Canada
Latest news
No headlines yet.
Stocktwits
Vextra
Nov 19, 10:14 PM
Look at ticker FGI spiking now. crazy!
If you want to be early for once look at FGI 🚀
FGI is just starting lets hope it pulls a OMH 2,000% type of run!!
$CAPT /
$QNTM /
$YCBD /
0 replies
FickleFin
Nov 19, 1:38 PM
$QNTM $GNS I can promise you 100% Its all a grift. 📉... ☠️
1 replies
FickleFin
Nov 18, 6:07 PM
$QNTM $GNS
they're selling on you... big red candles. 🤡
0 replies
FickleFin
Nov 16, 3:19 PM
$GNS $QNTM will keep getting new lows till split. Share price is being propped.
$QNTM Already tapped 1.33 while
$GNS still halted. That sell off is going to hit hard.
1 replies
FickleFin
Nov 16, 11:07 AM
$QNTM GAME OVER 📉📉 = ☠️
$GNS GAME OVER 📉📉 = ☠️
Kevin Baloney is still yapping... What a 🤡. Both shitcos have fucked retail over and over, year after year... the "i told you so"
1 replies
NetworkNewsWire
Nov 13, 7:37 PM
InvestorNewsBreaks –
$QNTM Reports
$12.22 Million in Cash and Digital Assets, Advances Lucid-MS Phase 2 Trial https://ibn.fm/phOJG
0 replies